← Back to Search

Intervention Arm: Virtual Group for Smoking

N/A
Recruiting
Led By Jean Wong, MD
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Self-reported smokers who have smoked cigarettes within the past 30 days
18+ years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up surgery: (i)day of recruitment, (ii)day of surgery, (iii) 7 day follow-up, (iv) 30 day follow-up; fracture clinic: (i)day of recruitment, (ii)7 day follow-up, (iii) 14 day follow-up, (iv) 30 day follow-up
Awards & highlights

Study Summary

This trial tests a virtual smoking cessation program to see if it's an effective way to help people quit smoking and reduce risks before surgery. #stopsmoking #smokefree

Who is the study for?
This trial is for adults over 18 who smoke cigarettes, whether daily or occasionally. They must be scheduled for elective surgery in at least 48 hours or visiting a fracture clinic within 14 days of injury/surgery and have an email address. It's not suitable for those who don't meet these criteria.Check my eligibility
What is being tested?
The study tests a virtual smoking cessation program against standard care to see if it helps people quit smoking before/after surgery or with bone fractures. It includes e-learning about smoking risks and tailored emails based on nicotine dependence and motivation to quit.See study design
What are the potential side effects?
Since this is a non-medical intervention focusing on education and support through email, there are no direct side effects like you'd expect from medication. However, participants may experience usual nicotine withdrawal symptoms when trying to quit.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have smoked cigarettes in the last 30 days.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~surgery: (i)day of recruitment, (ii)day of surgery, (iii) 7 day follow-up, (iv) 30 day follow-up; fracture clinic: (i)day of recruitment, (ii)7 day follow-up, (iii) 14 day follow-up, (iv) 30 day follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and surgery: (i)day of recruitment, (ii)day of surgery, (iii) 7 day follow-up, (iv) 30 day follow-up; fracture clinic: (i)day of recruitment, (ii)7 day follow-up, (iii) 14 day follow-up, (iv) 30 day follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Trial feasibility - Acceptability of e-learning module program component
Trial feasibility - Acceptability of the email message program component
Trial feasibility - EPIC patient portal usage
+2 more
Secondary outcome measures
Smoke
Complications/Adverse Events
Module Education
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention Arm: Virtual GroupExperimental Treatment1 Intervention
The intervention will involve participating in the study's virtual smoking cessation program. This program consists of 2 components: an e-learning module and a tailored email messaging program based on the participant's motivation to quit smoking and their Fagerstrom test for nicotine dependence score.
Group II: Control Arm: Standard CareActive Control1 Intervention
This arm will receive standard care which may or may not include brief advice to quit smoking from any of the healthcare providers. Providing smoking cessation intervention is not mandatory in standard care and may not be provided.

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,476 Previous Clinical Trials
485,080 Total Patients Enrolled
3 Trials studying Smoking
886 Patients Enrolled for Smoking
Jean Wong, MDPrincipal InvestigatorUniversity Health Network, Toronto
6 Previous Clinical Trials
580 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the extent of this clinical research's sample size?

"Affirmative. Clinicaltrials.gov records that this clinical trial, which was first posted on October 28th 2022, is presently recruiting volunteers. A total of 100 people are needed to be recruited from 1 location."

Answered by AI

Are there any vacancies available for the application process of this clinical trial?

"This medical trial, which was first publicized on October 28th 2022, is actively enrolling volunteers. Data hosted on clinicaltrials.gov reflects the most recent update occurring on December 7th 2023."

Answered by AI

What aims are researchers hoping to achieve with this experiment?

"The primary purpose of this trial, which will be monitored over a period of 30 days after surgery and recruitment, is to examine the feasibility of using an EPIC patient portal. This study also seeks to measure secondary outcomes such as Stage of Change (through Prochaska and DiClemente's Stages Model), readmissions from hospital records, and successful quit attempts since enrolment into the study."

Answered by AI
~40 spots leftby Apr 2025